• Poster

Comparative Cost-Efficacy Analysis of Darunavir/r and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in Germany

Citation

Brogan, A., Soorapanth, S., Donatz, V., Hill, A., & Smets, E. (2009, October). Comparative Cost-Efficacy Analysis of Darunavir/r and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in Germany. Presented at ISPOR 12th Annual European Congress, .

Abstract